INTERNATIONAL PATENT: RE-MED GROUP FILES APPLICATION FOR "MEBEVERINE DERIVATIVES FOR THE USES THEREOF IN THE TREATMENT OF AUTOIMMUNE DISEASES"

GENEVA, Feb. 2 -- RE-MED GROUP (25 A Boulevard Royal2449 LUXEMBOURG) filed a patent application (PCT/EP2025/071402) for "MEBEVERINE DERIVATIVES FOR THE USES THEREOF IN THE TREATMENT OF AUTOIMMUNE DISEASES" on Jul 24, 2025. With publication no. WO/2026/022327, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ABENHAIM, Lucien (1-10 Summers Street Flat 1LONDRES EC1R5BD), GRIMALDI, Lamiae (105-107 Rue de Sevres75006 PARIS), MORIDE, Yola (4540 Ch. Circle MontrealQuebec, H3W 1Y7)

Abstract: The present invention relates to the u...